Showing results (161-170 of 272) with videos related to

Sort By:
Pageof 28
The Kaohsiung Journal of Medical Sciences|April 23, 2026
Impact of Cardiometabolic Risk Factors and Steatotic Liver Disease on Liver-Related Outcomes in Patients With Chronic Hepatitis C After Curative Antiviral TherapyChung-Feng Huang, Yi-Hung Lin, Pei-Chien Tsai, et al.
The Kaohsiung Journal of Medical Sciences|January 16, 2017
A real-world impact of cost-effectiveness of pegylated interferon/ribavarin regimens on treatment-naïve chronic hepatitis C patients in TaiwanPei-Chien Tsai, Ta-Wei Liu, Meng-Hsuan Hsieh, et al.
Plos One|July 1, 2021
Anti-HCV antibody titer highly predicts HCV viremia in patients with hepatitis B virus dual-infectionHung-Yin Liu, Yi-Hung Lin, Pei-Ju Lin, et al.
Journal of the Chinese Medical Association : JCMA|June 2, 2021
The association between hepatitis C virus infection and renal functionGantsetseg Gantumur, Batbold Batsaikhan, Ching-I Huang, et al.
Biomedicines|November 11, 2022
Baseline Circulating miR-125b Levels Predict a High FIB-4 Index Score in Chronic Hepatitis B Patients after Nucleos(t)ide Analog TreatmentJyun-Yi Wu, Yi-Shan Tsai, Chia-Chen Li, et al.
The Kaohsiung Journal of Medical Sciences|November 17, 2021
Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein expression predicts disease severity in nonalcoholic steatohepatitis patientsTyng-Yuan Jang, Chung-Feng Huang, Ming-Lun Yeh, et al.
Medicine|April 4, 2015
Huge gap between clinical efficacy and community effectiveness in the treatment of chronic hepatitis C: a nationwide survey in TaiwanMing-Lung Yu, Ming-Lun Yeh, Pei-Chien Tsai, et al.
The American Journal of Gastroenterology|March 27, 2024
Long-term Risks of Cirrhosis and Hepatocellular Carcinoma Across Steatotic Liver Disease SubtypesYi-Ting Chen, Tzu-I Chen, Tsai-Hsuan Yang, et al.
The Kaohsiung Journal of Medical Sciences|March 29, 2025
Circulating let-7 Predicts Hepatic Fibrogenesis of 12-Month Post-Nucleos(t)ide Analog Treatment in Patients With Hepatitis B VirusYi-Shan Tsai, Po-Cheng Liang, Yi-Hung Lin, et al.
Hepatology International|July 3, 2026
Prevalence and associated factors of metabolic dysfunction-associated steatotic liver disease in Taiwan, 2001-2021Ming-Lun Yeh, Pei-Chien Tsai, Chung-Feng Huang, et al.
Pageof 28